Neurologic Diseases and Neurogenetics
PRINCIPAL INVESTIGATORS
- Serge Jauma Classen
- Monica Povedano Panades
- Ramon Reñe Ramirez
- Joan Prat Rojo
- Jordi Gascon Bayarri
- Lucia Aja Rodriguez
- Matilde Calopa Garriga
- Pere Cardona Portela
- Mercedes Falip Centellas
- Júlia Miró Lladó
- Sergio Martinez Yelamos
CLINICAL RESEARCHERS
- Pere Domenech Santasusana
- Misericordia Veciana De Las Heras
- Lucia Romero Pinel
- Jaume Campdelacreu Fumadó
- Dolores Dot Bach
- Helena Quesada Garcia
- Mariano Huerta Villanueva
- Elisabet Matas Martin
- Sara Yagüe Jimeno
- Raul Dominguez Rubio
- Elisabet Romero Gangonells
- Pablo Arroyo Pereiro
- Blanca Lara Rodriguez
- Andres Julian Paipa Merchan
- Velina Nedkova Hristova
- Isabel Fernandez Conejero
- Belén González Herrero
PREDOCTORAL RESEARCHERS (R1)
- Silvia Muñoz Quiñones
- Laura Diez Porras
- Carla Marco Cazcarra
SCIENTIFIC SUPPORT
- Laura Bau Vila
- Vanesa Adell Ortega
- Abdelilah Assialioui Essanhaji
- Sheila Álvarez Fornieles
MANAGEMENT SUPPORT
- Susana Pobla Müller
- José Luis Moreno Morejón
Neuroscience
Neuroscience
Scientific production
43
PAPERS
Impact factor: 133,818
7 PUBLICATIONS IN FIRST DECILE
16 PUBLICATIONS IN FIRST QUARTILE
Selected publications
- Velez-Santamaria, Valentina; Nedkova, Velina; Diez, Laura; Homedes, Christian; Alberti, M. Antonia; Casasnovas, Carlos. Eculizumab as a promising treatment in thymoma-associated myasthenia gravis. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 10.1177/1756286420932035
- Siegler JE; Cardona P; Arenillas JF; Talavera B; Guillen AN; Chavarría-Miranda A; de Lera M; Khandelwal P; Bach I; Patel P; Singla A; Requena M; Ribo M; Jillella DV; Rangaraju S; Nogueira RG; Haussen DC; Vazquez AR; Urra X; Chamorro Á; Román LS; Thon JM; Then R; Sanborn E; de la Ossa NP; Millàn M; Ruiz IN; Mansour OY; Megahed M; Tiu C; Terecoasa EO; Radu RA; Nguyen TN; Curiale G; Kaliaev A; Czap AL; Sebaugh J; Zha AM; Liebeskind DS; Ortega-Gutierrez S; Farooqui M; Hassan AE; Preston L; Patterson MS; Bushnaq S; Zaidat O; Jovin TG. EXPRESS: Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. INTERNATIONAL JOURNAL OF STROKE. 10.1177/1747493020959216
- Romero-Gangonells, Elisabet; Nuria Virgili-Casas, M.; Dominguez-Rubio, Raul; Povedano, Monica; Perez-Saborit, Nuria; Calvo-Malvar, Nahum; Barcelo, Maria A.. Evaluation of Dysphagia in Motor Neuron Disease. Review of Available Diagnostic Tools and New Perspectives. DYSPHAGIA. 10.1007/s00455-020-10170-7
- Miro, Julia; Ripolles, Pablo; Sierpowska, Joanna; Santurino, Mila; Juncadella, Montserrat; Falip, Merce; Rodriguez-Fornells, Antoni. Autobiographical memory in epileptic patients after temporal lobe resection or bitemporal hippocampal sclerosis. BRAIN IMAGING AND BEHAVIOR. 10.1007/s11682-019-00113-8
- Andrés-Benito P, Gelpi E, Jové M, Mota-Martorell N, Obis È, Portero-Otin M, Povedano M, Pujol A, Pamplona R, Ferrer I . Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 10.1111/nan.12681
Research highlights
PROJECTS
2 ongoing projects
58 ongoing clinical trials
18 started clinical trials
PUBLISHED WORKS
2 clinical guidelines
5 Ongoing theses
Selected projects
- Estudio de fase 3, multicéntrico, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para evaluar la eficacia y la seguridad de aducanumab (BIIB037) en pacientes con enfermedad de Alzheimer temprana (2016 – 2020) PI: REÑE RAMIREZ, RAMON. Funder: BIOGEN IDEC RESEARCH LIMITED.
- A global, phase 2, randomized, double-blind, placebo-controlled, response-adaptive dose-ranging study of BMS-986177, an oral factor XIA inhibitor, for the prevention of new ischemic stroke or new covert brain infarction in patients receiving Aspirin and Clopindogrel following acute ischemic stroke or transient ischemic attack (TIA) (2019 – 2021) PI: CARDONA PORTELA, PERE. Funder ref.: CV010-031.
- A phase III, multicenter, randomized, parallel group, double blind, double dummy, active controlled study of Evobrutinib compared with Teriflunomide, in participants with relapsing multiple sclerosis to evaluate efficacy and safety (2020 – 2021) PI: MARTINEZ YELAMOS, SERGIO. Funder ref.: MS200527_0080.
- Evaluación de la toma de imágenes ponderadas por difusión (DWI) y de la tomografía computarizada de perfusión (TCP) con discordancia clínica en la priorización de accidentes cerebrovasculares de tiempo de inicio desconocido y de aparición tardía durante neurointervenciones (DAWN) (2016 – 2020) PI: CARDONA PORTELA, PERE. Funder: Stryker European Operations BV .
- A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsy (2020 – 2021) PI: FALIP CENTELLAS, MERCEDES. Funder ref.: EP0092.